Metabolic aspects of hypertension control: are all antihypertensive agents equal?
- III. interní klinika, Všeobecná fakultní nemocnice a 1. lékařská fakulta Univerzity Karlovy, Praha, Česká republika
This brief overview discusses the potential differences in the metabolic action of different classes of antihypertensive agents in relation to the development of diabetes mellitus. A meta-analysis of large studies of antihypertensive therapy has shown renin-angiotensin system inhibitors are associated with the lowest risk of developing new-onset diabetes mellitus. New-onset diabetes mellitus may significantly raise the cardiovascular risk in the long run.
Keywords: Metabolic effects; Hypertension; Therapy
Published: March 1, 2005 Show citation